Leigh Baldwin & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$218K Buy
+1,385
New +$219K 0.11% 167

Other funds holding XBI

Leigh Baldwin & Co's XBI Position: Q3 2026 in Review

Leigh Baldwin & Co opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 1,385 shares worth $218K. The stake represents 0.11% of the portfolio and ranks #167 among its holdings.

952 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Leigh Baldwin & Co held 1,385 shares of State Street SPDR S&P Biotech ETF worth $218K as of Q3 2026.
  • State Street SPDR S&P Biotech ETF was a new Leigh Baldwin & Co position in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up 0.11% of Leigh Baldwin & Co's portfolio in Q3 2026, its #167 holding.
  • 952 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Leigh Baldwin & Co's 13F filing for Q3 2026, filed 13 Nov 2026.